Company
Headquarters: Tianjin, China
Employees: 527
CN¥4.54 Billion
CNY as of Jan. 1, 2024
US$639.0 Million
Company | Market Cap (USD) |
---|---|
Abbott | $192.67 B |
Stryker Corporation | $113.24 B |
Medtronic | $111.60 B |
Boston Scientific Corporation | $85.22 B |
Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Sino Medical Sciences Technology Inc., a medical device company, engages in the research, development, production, and distribution of interventional devices in China. Its products include drug-eluting stents, balloon catheters, coronary stents, and transcatheter mitral valve replacement devices. Sino Medical Sciences Technology Inc. has a clinical collaboration agreement with The National University of Ireland Galway. The company was founded in 2007 and is headquartered in Tianjin, China.
Top 1-year algo backtest: +298.72%
$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Sino Medical Sciences Technology, Inc. has the following listings and related stock indices.
Stock: SSE: 688108 wb_incandescent